Clinique Chenieux
About Clinique Chenieux
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
UNICANCER
5
Federation Francophone de Cancerologie Digestive
4
Janssen Research & Development, LLC
3
Averitas Pharma, Inc.
1
Centre Hospitalier Universitaire Dijon
1
Exactech
1
GERCOR - Multidisciplinary Oncology Cooperative Group
1
Monopar Therapeutics
1
NSABP Foundation Inc
1
National Cancer Institute (NCI)
1
National Cancer Institute, France
1
Clinical Trials at Clinique Chenieux
During the past decade, Clinique Chenieux conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on
average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
2002-06-01
Unknown status
Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery
2006-05-01
Completed
3,400
Comparison of Autologous Chondrocyte Implantation Versus Mosaicoplasty: a Randomized Trial
2007-04-01
2013-08-01
Completed
58
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509
Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
2010-05-27
2018-12-09
Completed
297
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
2012-04-01
2016-07-01
Terminated
222
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
2010-04-01
2014-12-01
Completed
183
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Clinique Chenieux" #1 sponsor was "UNICANCER" with 5 trials, followed by "Federation Francophone de Cancerologie Digestive" with 4 trials
sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Averitas Pharma, Inc." with 1 trials sponsored and "Centre Hospitalier Universitaire Dijon"
with 1 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Chenieux"
#1 collaborator was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "National Cancer Institute, France" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Cancer International Research Group (CIRG)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Clinique Chenieux
According to Clinical.Site data, the most researched conditions in "Clinique Chenieux" are
"Urinary Bladder Neoplasms" (3 trials), "Breast Cancer" (2 trials), "Acute Kidney Injury (AKI)" (1 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials) and "Adenocarcinoma of the Oesogastric Junction (Siewert Type I or II)" (1 trials). Many other conditions were trialed in "Clinique Chenieux" in a lesser frequency.
Clinical Trials Intervention Types at Clinique Chenieux
Most popular intervention types in "Clinique Chenieux" are "Drug" (19 trials), "Biological" (6 trials), "Procedure" (4 trials), "Radiation" (4 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Cetrelimab" (3 trials), "TAR-200" (3 trials), "adjuvant therapy" (3 trials), "Docetaxel" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinique Chenieux
The vast majority of trials in "Clinique Chenieux" are
21 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at Clinique Chenieux
Currently, there are NaN active trials in "Clinique Chenieux".
undefined are not yet recruiting,
10 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Clinique Chenieux,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Clinique Chenieux, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".